The ESTIMATE algorithm was employed to evaluate the association of FCRLA with tumor stromal cells and tumor immune cells, which may provide a new reference for immune therapy due to the enrichment of FCRLA in tumor stromal cells and immune cells (Figure 9D–F). This evidence concerns the gene FCRLA and neoplasm.